GEN Exclusives

More »
Readers Comments Back to Item »

Preliminary Thoughts on the Implications of Prometheus v. Mayo for Biotechnology

1 Readers' Comments

Posted by: Michal Svoboda


Amidst the general outcry on the Prometheus ruling and sofisticated law finesses the main reason why the patent should never have been granted - obviousness - has never been mentioned.

"Those skilled in the art" know well the therapeutic drug monitoring is widely used for at least half a century (see e.g. a review by S.L.Cohan at Those skilled in the art also know all too well that if the drug level itself is not a meaningful measure of efficacy or toxicity a suitable metabolite should be sought for.

The takehome lesson for the industry is that we should concentrate on improvement in the method of to determine the drug level, where there is ample field for radical innovation rather than trying to patent the obvious principle.

  • Click here to Login or to Register for free.

    You will be taken back to your selected item after Login/Registration.


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

The Triple Package and Success

One theory for explaining “success," put forward by Amy Chua Jed Rubenfeld, posits cultural traits such as a superiority complex, personal insecurity and impulse control. Union College professors Joshua Hart and Christopher Chabris counter that intelligence, conscientiousness, and economic advantage are the most likely elements of success, regardless of ethnicity. Do you think that Hart-Chabris make a better argument for achieving success than the Chua-Rubenfeld theory?

More »